David Butuk, MD
Family Medicine · Meridian, IDNPI 1942250972
Payments from drug & device makers
Across 3,064 payments — averaging $4972.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$7.4M
- Eli Lilly$3.7M
- Merck$1.2M
- Novo Nordisk AS$793K
- Boehringer Ingelheim$673K
- Novartis$386K
- plus $1.2M from 18 others
Across 8 payments — averaging $3611.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$29K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 478 | $7,377,398 |
| Eli Lilly | 47 | $3,652,889 |
| Merck | 64 | $1,166,115 |
| Novo Nordisk AS | 2,036 | $792,742 |
| Boehringer Ingelheim | 50 | $672,975 |
| Novartis | 12 | $386,041 |
| AstraZeneca | 17 | $348,711 |
| Amgen | 2 | $278,610 |
| AbbVie | 57 | $215,801 |
| Takeda Pharmaceuticals U.S.A., Inc. | 76 | $174,813 |
| Acrotech Biopharma Inc. | 6 | $70,415 |
| Boehringer Ingelheim International GmbH | 155 | $39,609 |
| Shire North American Group Inc | 14 | $29,059 |
| Esperion Therapeutics, Inc. | 31 | $18,419 |
| Eli Lilly Export S.A. Puerto Rico Branch | 1 | $6,984 |
| Kowa Research Institute, Inc. | 5 | $6,131 |
| Novo Nordisk | 4 | $80 |
| Astellas Pharma US Inc | 3 | $69 |
| Sanofi Pasteur Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$15,236,960 in reported general payments places this provider in the 95th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Meridian
- Mark TurnerMeridian$40.5M
- Elaine DavidsonMeridian$303K
- Timothy McHughMeridian$176K
- Mark JohnsonMeridian$10K
- Jason LudwigMeridian$7K
- Jacob SmithMeridian$7K
- Ginger AllenMeridian$6K
- George ThomasMeridian$6K
- Aaron MoorhouseMeridian$5K
- Gary SoucieBlackfoot$5.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.